L. Merrick

Multicenter Evaluation of the VERSANT Hepatitis B Virus DNA 3.0 Assay

Joseph D. C. Yao, L. Oon, M. Beld, 2004, Journal of Clinical Microbiology.

Comprehensive comparison of the VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 MONITOR 1.5 assays on 1,000 clinical specimens.

L. Merrick, R. Ziermann, M. Friesenhahn, 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

HIV serology signal-to-cutoff ratio as a rapid method to predict confirmation of HIV infection

L. Merrick, C. Lowe, D. Puddicombe, 2018, European Journal of Clinical Microbiology & Infectious Diseases.

Targeted management of influenza A/B outbreaks incorporating the cobas® Influenza A/B & RSV into the virology laboratory.

L. Merrick, C. Lowe, G. Ritchie, 2019, The Journal of hospital infection.

Implementation of Next-Generation Sequencing for Hepatitis B Virus Resistance Testing and Genotyping in a Clinical Microbiology Laboratory

T. Mazzulli, P. Harrigan, C. Sherlock, 2015, Journal of Clinical Microbiology.

Increase in Hospital Admissions for Severe Influenza A/B among Travelers on Cruise Ships to Alaska, 2015

D. Skowronski, L. Merrick, C. Lowe, 2018, Emerging infectious diseases.

Use of Sno Strip Filter-Paper Wicks for Collection of Genital-Tract Samples Allows Reproducible Determination of Human Immunodeficiency Virus Type 1 (HIV-1) RNA Viral Load with a Commercial HIV-1 Viral Load Assay

D. Money, C. Sherlock, L. Merrick, 2006, Journal of Clinical Microbiology.